Charu Gupta1, An N Massaro2,3, Patricio E Ray4,5,6. 1. Division of Nephrology, Children's National Health System, Washington, DC, USA. 2. Division of Neonatology, Children's National Health System, Washington, DC, USA. 3. Department of Pediatrics, The George Washington University School of Medicine-Children's National Medical Center, 111 Michigan Avenue, NW, Washington, DC, 20010, USA. 4. Division of Nephrology, Children's National Health System, Washington, DC, USA. Pray@cnmc.org. 5. Center for Genetic Medicine Research, Children National Health System, Washington, DC, USA. Pray@cnmc.org. 6. Department of Pediatrics, The George Washington University School of Medicine-Children's National Medical Center, 111 Michigan Avenue, NW, Washington, DC, 20010, USA. Pray@cnmc.org.
Abstract
BACKGROUND: Current definitions of acute kidney injury (AKI) are not sufficiently sensitive to identify all newborns with AKI during the first week of life. METHODS: To determine whether the rate of decline of serum creatinine (SCr) during the first week of life can be used to identify newborns with AKI, we reviewed the medical records of 106 term neonates at risk of AKI who were treated with hypothermia for hypoxic ischemic encephalopathy (HIE). RESULTS: Of the newborns enrolled in the study, 69 % showed a normal rate of decline of SCr to ≥50 % and/or reached SCr levels of ≤0.6 mg/dl before the 7th day of life, and therefore had an excellent clinical outcome (control group). Thirteen newborns with HIE (12 %) developed AKI according to an established neonatal definition (AKI-KIDGO group), and an additional 20 newborns (19 %) showed a rate of decline of SCr of <33, <40, and <46 % from birth to days 3, 5, or 7 of life, respectively (delayed rise in estimated SCr clearance group). Compared to the control group, newborns in the other two groups required more days of mechanical ventilation and vasopressor drugs and had higher gentamicin levels, more fluid overload, lower urinary epidermal growth factor levels, and a prolonged length of stay. CONCLUSIONS: The rate of decline of SCr provides a sensitive approach to identify term newborns with AKI during the first week of life.
BACKGROUND: Current definitions of acute kidney injury (AKI) are not sufficiently sensitive to identify all newborns with AKI during the first week of life. METHODS: To determine whether the rate of decline of serum creatinine (SCr) during the first week of life can be used to identify newborns with AKI, we reviewed the medical records of 106 term neonates at risk of AKI who were treated with hypothermia for hypoxic ischemicencephalopathy (HIE). RESULTS: Of the newborns enrolled in the study, 69 % showed a normal rate of decline of SCr to ≥50 % and/or reached SCr levels of ≤0.6 mg/dl before the 7th day of life, and therefore had an excellent clinical outcome (control group). Thirteen newborns with HIE (12 %) developed AKI according to an established neonatal definition (AKI-KIDGO group), and an additional 20 newborns (19 %) showed a rate of decline of SCr of <33, <40, and <46 % from birth to days 3, 5, or 7 of life, respectively (delayed rise in estimated SCr clearance group). Compared to the control group, newborns in the other two groups required more days of mechanical ventilation and vasopressor drugs and had higher gentamicin levels, more fluid overload, lower urinary epidermal growth factor levels, and a prolonged length of stay. CONCLUSIONS: The rate of decline of SCr provides a sensitive approach to identify term newborns with AKI during the first week of life.
Authors: Dirk P Boer; Yolanda B de Rijke; Wim C Hop; Karlien Cransberg; Eiske M Dorresteijn Journal: Pediatr Nephrol Date: 2010-05-27 Impact factor: 3.714
Authors: Seetha Shankaran; Abbot R Laptook; Scott A McDonald; Rosemary D Higgins; Jon E Tyson; Richard A Ehrenkranz; Abhik Das; Guilherme Sant'Anna; Ronald N Goldberg; Rebecca Bara; Michele C Walsh Journal: Pediatr Crit Care Med Date: 2012-01 Impact factor: 3.624
Authors: Suma Bhat Hoffman; An N Massaro; Angel A Soler-García; Sofia Perazzo; Patricio E Ray Journal: Pediatr Nephrol Date: 2013-06-20 Impact factor: 3.714
Authors: J K Lee; J Perin; C Parkinson; M O'Connor; M M Gilmore; M Reyes; J Armstrong; J M Jennings; F J Northington; R Chavez-Valdez Journal: J Perinatol Date: 2017-05-04 Impact factor: 2.521
Authors: Adam Frymoyer; Krisa P Van Meurs; David R Drover; Jelena Klawitter; Uwe Christians; Valerie Y Chock Journal: Pediatr Res Date: 2020-09-12 Impact factor: 3.756
Authors: Özgün Uygur; Özge Altun Köroğlu; Reşit Ertürk Levent; Eser Sözmen; Firat Ergin; Yüksel Atay; Mehmet Yalaz; Mete Akisü; Nilgün Kültürsay Journal: Turk J Med Sci Date: 2021-02-26 Impact factor: 0.973